Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study.

• Authors: KAPPOS Ludwig; GOLD Ralf; MILLER David H.; MACMANUS David G.; HAVRDOVÁ Eva; LIMMROTH Volker; POLMAN Chris H.; SCHMIERER Klaus; YOUSRY Tarek A.; YANG Minhua; ERAKSOY Mefkure; MELUZÍNOVÁ Eva; REKTOR Ivan; DAWSON Katherine D.; SANDROCK Alfred W.; O'NEILL Gilmore N.
• Year of publication: 2008
• Type: Article in Periodical
• Magazine / Source: Lancet
• MU Faculty or unit: Faculty of Medicine
• Field: Neurology, neurosurgery, neurosciences
• Keywords: Multiple sclerosis; multicentre; randomised; placebo
• Description: Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study.

Related projects

• The internal organisation and neurobiological mechanisms of functional CNS systems under normal and pathological conditions.